ICYMI: Cancer death rate continues to decline due to treatment advances

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to...
Read More
Novel medicines approved in 2022 offer increased treatment options for patients

2022 marked another year of significant progress by biopharmaceutical research companies conducting lifesaving research and development for innovative medicines with a total of 45 new medicine...
Read More
ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference

This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed...
Read More
Study finds hepatitis C cure saved Medicaid $15 billion

New research published in the American Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly,...
Read More
New data show how insurers and middlemen shift Rx costs onto patients

There is only one place in the health care system where middlemen refuse to share negotiated prices with patients, and that’s at the pharmacy counter. A new report reveals how this harmful tactic...
Read More
Busting 3 Myths About Copay Coupons

Insurer-imposed barriers like high deductibles and coinsurance shift the cost of life-saving care onto patients. Manufacturers and others have stepped forward to assist patients who face high...
Read More
Making coupons count for patients at the pharmacy counter

Too many patients face high out-of-pocket costs for brand medicines, even when they have insurance.
Read More
By the Numbers: Patients lose when the government sets prices

Yet again, Congress is considering harmful drug pricing policies with complete disregard for the negative impact they will have on patients and our economy. At the same time, they are continuing to...
Read More
Prescription drug prices are not fueling inflation

Inflation is causing pain for people across the country. As policymakers search for ways to help provide relief, some are erroneously tying inflation to prescription medicines. To make matters worse,...
Read More
In comments to federal agency, PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for prescription medicines

In comments submitted to the Federal Trade Commission (FTC), PhRMA urged the agency to examine how pharmacy benefit managers (PBMs) leverage their extraordinary power to maximize profits, often in...
Read More